Keywords: r-pr, riluzole, effective, als, rhone-poulenc, rorer, antiglutamate
R-PR'S RILUZOLE EFFECTIVE IN ALS
Article | 07 March 1994
Rhone-Poulenc Rorer's riluzole, an antiglutamate drug, may be an effective treatment for amyotrophic lateral sclerosis, according to a study published ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
